https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-01 / Int J Hyperthermia 2005 Dec;21(8):723-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-01 / Int J Hyperthermia 2005 Dec;21(8):723-92005-12-01 00:00:002019-02-15 09:17:45Thermal regulation of lymphocyte trafficking: hot spots of the immune response
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-01 / Expert Opin Biol Ther 2005 Dec;5(12):1627-33
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-01 / Expert Opin Biol Ther 2005 Dec;5(12):1627-332005-12-01 00:00:002019-02-15 09:22:16Virus-based therapies for colon cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-01 / Clin. Exp. Immunol. 2005 Dec;142(3):555-68
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-01 / Clin. Exp. Immunol. 2005 Dec;142(3):555-682005-12-01 00:00:002019-02-15 08:49:34Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-12-01 / Pathology 2005 Dec;37(6):534-50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-12-01 / Pathology 2005 Dec;37(6):534-502005-12-01 00:00:002019-02-15 08:51:27Vaccine strategies to treat lymphoproliferative disorders
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-29 / Cancer Immunol. Immunother. 2006 Oct;55(10):1238-46
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-29 / Cancer Immunol. Immunother. 2006 Oct;55(10):1238-462005-11-29 00:00:002019-02-15 09:19:48Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-26 / Cancer Immunol. Immunother. 2006 Aug;55(8):1011-62005-11-26 00:00:002019-02-15 09:19:50Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-95
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-20 / Int. J. Cancer 2005 Nov;117(4):587-952005-11-20 00:00:002019-02-15 08:38:52Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-15 / Immunol. Lett. 2006 Mar;103(2):142-82005-11-15 00:00:002005-11-15 00:00:00Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-14 / World J. Gastroenterol. 2005 Nov;11(42):6571-62005-11-14 00:00:002019-02-15 09:11:49Immunological treatment of liver tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-11-10 / J. Clin. Oncol. 2005 Nov;23(32):8262-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-11-10 / J. Clin. Oncol. 2005 Nov;23(32):8262-92005-11-10 00:00:002019-02-15 09:24:19Prostate cancer immunology: biology, therapeutics, and challenges
